A multilocular B-cell neoplasia presenting as multiple myeloma and polymorphic lymphoma of recipient origin 2 months after kidney transplantation in a heart-transplant recipient

Nephrology Dialysis Transplantation

Volumn 11, Issue 10, 1996, Pages 2085-2087

  Haas, M ^a   Mannhafter, Ch ^b   Ullrich, R ^b   Schwarzinger, I ^b   Zuckermann, A ^b   Derfler, K ^a   Jager U ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Heart transplant; Immunosuppression; Polymorphic lymphoma; Renal transplant

Indexed keywords

AZATHIOPRINE; CORTISONE; IMMUNOSUPPRESSIVE AGENT; OKT 3;

ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPHOMA; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; RECIPIENT;

EID: 0029962541     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027105     Document Type: Article

References (17)

1. Penn I. The changing pattern of posttransplant malignancies. Transplantation Proc 1991; 23(1): 1101-1103
2. Sheil AGR, Flavel S, Disney APS, Matthew TH. Cancer in dialysis and transplant patients. Transplantation Proc 1985; 12(1): 195-198
3. Opelz G. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514-1516
4. London N, Farmery SM, Will EJ, Davison AM, Lodge JPA. Risk of neoplasia in renal transplant patients. Lancet 1995; 346: 403-406
5. Weintraub J, Wanke RA. Lymphoma in cardiac allotransplant recipients. Transplantation 1982; 33(4): 347-351
6. Sklarin NT, Dutcher JP, Wiernik PH. Lymphomas following cardiac transplantation. Case report and review of the literature. Am J Hematol 1991; 37: 105-111
7. Kalra PA, Wood GN, O'Donoghue DJ et al. Complete regression of recurrent diffuse malignant lymphoma after withdrawal of cyclosporin A in a renal transplant recipient. Nephrol Dial Transplant 1994; 9(8): 1197-1200
8. Couetil JP, McGoldrick JP, Wallwork J, English TAH. Malignant tumors after heart transplantation. J Heart Transplant 1990; 9: 622-626
9. Sioutos N, Bagg A, Michand G et al. PCR vs Southern blot (SB) hybridization: detection of immunoglobulin heavy chain (IgH) gene rearrangement. Blood(Abstract) 1993; 82: 45
10. Gaiger A, Mannhalter C, Hinterberger W et al. Detection of engraftment and mixed chimerism following bone marrow transplantation using PCR amplification of a highly variable region - variable number of tandem repeats (VNTR) in the von Willebrand factor gene. Ann Hematol 1991; 63: 227-228
11. Knowles DM, Cesarman E, Chadburn A et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995; 85(2): 552-565
12. Gaston JSH, Rickinson AB, Epstein MA. Epstein-Barr virus specific T-cell memory in renal allograft recipients under long term immunosuppression. Lancet 1982; April 24: 923-925
13. Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RI and Najarian JS. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 1981; 41: 4253-4261
14. Weissmann DJ, Ferry JA, Harris NL, Louis DN, Delmonico F, Spiro I. Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. Am J Clin Pathol 1995; 103: 748-755
15. Shustik C, Jamison BM, Alfieri C, Scherer S, Loertscher R. A solitary plasmacytoma of donor origin arising 14 years after kidney allotransplantation. Br J Haematol 1995; 91: 167-168
16. Morrison VA, Dunn DL, Manivel C, Gajil-Peczalska KJ, Peterson BA. Clinical characteristics of post-transplant lymphoproliferation disorders. Am J Med 1994; 94: 14-24
17. Witherspoon RP, Fisher LD, Schoch G et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784-789